|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows provided by operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Goodwill impairment | |||||
| Impairment of non-financial assets | |||||
| Impairment of operating right-of-use assets and related property, plant and equipment | |||||
| Reduction in carrying value of operating right-of-use assets | |||||
| Loss on equity method investments | |||||
| Acquisition-related gain | |||||
| Charge on cash flow hedge | |||||
| Amortization of financing costs and debt discount | |||||
| Stock compensation expense | |||||
| Loss on extinguishment of debt | |||||
| Loss on issuance of debt | |||||
| Deferred tax benefit | |||||
| Unrealized foreign exchange movements | |||||
| Other non-cash items | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Unbilled revenue | |||||
| Unearned revenue | |||||
| Other net assets | |||||
| Net cash provided by operating activities | |||||
| Cash flows used in investing activities: | |||||
| Purchase of property, plant and equipment | |||||
| Purchase of subsidiary undertakings (net of cash acquired) | |||||
| Investment in equity method investments | |||||
| Loan to equity method investment | |||||
| Sale of available for sale investments | |||||
| Purchase of available for sale investments | |||||
| Movement of available for sale investments | |||||
| Proceeds from investments in equity | |||||
| Purchase of investments in equity | |||||
| Net cash used in investing activities | |||||
| Financing costs | |||||
| Cash flows used in financing activities: | |||||
| Debt issue costs | |||||
| Drawdown of credit lines and loan facilities | |||||
| Repayment of credit lines and loan facilities | |||||
| Proceeds from exercise of equity compensation | |||||
| Share issue costs | |||||
| Repurchase of ordinary shares | |||||
| Share repurchase costs | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate movements on cash | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...